Your session is about to expire
← Back to Search
Behavioural Intervention
Somatic IVR (s-IVR) for Neuropathic Pain
Phase 3
Waitlist Available
Research Sponsored by Kathleen Friel
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, post-intervention, and 1 month follow up
Awards & highlights
Study Summary
The investigators hypothesize that SCI patients using immersive IVR training will show improved reduction of neuropathic pain that will outlast the training sessions and transfers into daily life.
Eligible Conditions
- Neuropathic Pain
- Spinal Cord Injury
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, post-intervention, and 1 month follow up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, post-intervention, and 1 month follow up
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Neuropathic Pain Scale
Secondary outcome measures
Beck Depression Inventory
Immersive Tendencies Questionnaire (ITQ)
Modified Ashworth Scale
+5 moreTrial Design
2Treatment groups
Active Control
Group I: Somatic IVR (s-IVR)Active Control1 Intervention
This group will use an Immersive Virtual Reality (Gear VR) device to focus on encouraging disassociation between pain and visualization and movement of the affected limbs. Subjects in this group will be exposed to an IVR environment that cycles them through a series of stretching and mobility exercises for the affected limbs bilaterally.
Group II: Distractive IVR (d-IVR)Active Control1 Intervention
This group will use an Immersive Virtual Reality (Gear VR) device to focus on distracting the subject from the pain. Subjects in this group will be exposed to a variety of engaging landscape IVR environments, without the ability to visualize their own body.
Find a Location
Who is running the clinical trial?
Kathleen FrielLead Sponsor
1 Previous Clinical Trials
30 Total Patients Enrolled
Kathleen Friel, PhDStudy DirectorBurke Medical Research Institute
4 Previous Clinical Trials
112 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger